Cardiovascular outcomes in children with Kawasaki disease: a population-based cohort study

Cal Robinson1,2, Rahul Chanchlani3,4,5, Anastasia Gayowsky5

  • 1Department of Pediatrics, McMaster University, Hamilton, ON, Canada.

Pediatric Research
|November 15, 2022
PubMed

Insights

Children with Kawasaki disease (KD) face a higher risk of cardiovascular events after recovery, but a lower risk of death. Enhanced cardiac surveillance is recommended for KD survivors to manage long-term cardiovascular health.

Area of Science:

  • Pediatric Cardiology
  • Epidemiology
  • Public Health

Background:

  • Kawasaki disease (KD) is a critical pediatric illness with uncertain long-term cardiovascular event risks.
  • Understanding post-illness cardiovascular outcomes is essential for patient management.

Purpose of the Study:

  • To determine the incidence and risk of cardiovascular events and mortality in pediatric Kawasaki disease survivors.
  • To compare cardiovascular outcomes in KD survivors versus a matched non-exposed cohort.

Main Methods:

  • A population-based retrospective cohort study utilized Ontario health administrative databases.
  • Pediatric KD hospitalizations (ages 0-18) from 1995-2018 were analyzed, with cases matched to 100 controls.
  • Major adverse cardiac events (MACE) and composite cardiovascular events were primary and secondary outcomes, analyzed using multivariable Cox models.

Main Results:

  • Among 4597 KD survivors, 1.7% experienced MACE and 13.8% had composite cardiovascular events over an 11-year median follow-up.
  • KD survivors showed increased risks of MACE and composite cardiovascular events at various time points post-discharge.
  • The incidence of ischemic heart disease and arrhythmias was notable in KD survivors; however, mortality risk was lower (aHR 0.36).

Conclusions:

  • Kawasaki disease survivors face a heightened risk of post-discharge cardiovascular events.
  • Despite increased cardiovascular event risk, KD survivors exhibit a lower mortality risk compared to non-exposed individuals.
  • Enhanced cardiovascular surveillance and preventative counseling are crucial for managing long-term health in childhood KD survivors.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
44
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
29
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
26
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
25